Role of APCC in managing Hemophilia with inhibitors

Role of APCC in managing Hemophilia with inhibitors

Saturday, April 19th 2025 - 2:30 PM (IST)

12 days to Go

29 doctors attending

Saturday, April 19th 2025 - 2:30 PM (IST)

ABOUT THIS SESSION

Brought to you by Takeda, this session will explore the critical role of Activated Prothrombin Complex Concentrate (APCC) in managing hemophilia patients with inhibitors, focusing on its mechanism, clinical efficacy, and practical application. Dr. Pawan Sulaniya, Associate Professor, Department of Pediatrics, JK LON Hospital, SMS Medical Hospital, Jaipur, will discuss the challenges posed by inhibitors, the pharmacokinetics of APCC, and its role in controlling breakthrough bleeding and perioperative hemostasis. The session will highlight clinical evidence, dosing strategies, monitoring considerations, and potential complications, providing an evidence-based approach to optimizing APCC use for better patient outcomes.

KEY DETAILS

Registration

Free

Duration

60 min

Replay

Yes

Certificate

No

Language

English

SHARE THIS SESSION

https://medflix.app/discussion/732534e8-ba64-4a18-8eb8-178e48d49b4e?utm_source=DiscPage&utm_medium=Share

Disclaimer

About: Medflix is owned and operated by Plexus Professionals Network Pvt. Ltd. and is being used by Takeda under an appropriate agreement for providing you access to webinars.

  1. You should not allow the contents shared in the webinar or online platform to substitute for your own independent medical judgment, which you should exercise in evaluating the information on this platform and should not be used for diagnosing or treating a health problem or disease.
  2. Nothing in this webinar or online platform should be construed as the giving of advice or the making of a recommendation regarding any decision or action related to your patient’s health, nor it is intended for use in the diagnosis of disease or other conditions, or the cure, mitigation, treatment, or prevention of disease.
  3. This online platform contains copyright protected information, content; the use of which is limited by law and this material cannot be reproduced, replicated, used or modified by any person for their own use or further distribution.
  4. Takeda does not warrant that any content or information contained on this online platform is accurate, correct, complete or up-to-date, and hereby disclaims any and all liability to any person for any actual or threatened loss or damage caused by errors or omissions, whether such errors or omissions result from negligence, accident or otherwise. Takeda assumes no liability for the interpretation and/or use of the content and/or information contained on this online platform, nor does it offer any warranty of any kind, either expressed or implied in relation to such content or information.
  5. Takeda takes no responsibility for and will not be liable for the technical reasons for unavailability of the webinar or the online-platform due to technical issues beyond Takeda’s control.

Copyright © 2023 Takeda Pharmaceutical Company Limited. All rights reserved. Contact us: Takeda Biopharmaceuticals India Private Limited (formerly known as Baxalta Bioscience India Pvt. Ltd.) 6th Floor, Tower-C, Building No.8, DLF Cyber City, DLF Phase-II, Gurgaon-122002, Haryana, India Tel +91-124-4559100 www.takeda.com Takeda - Better Health, Brighter Future Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Note: This page may be accessed by healthcare/allied healthcare professionals only.